MERIT MEDICAL SYSTEMS INC (MMSI) Fundamental Analysis & Valuation

NASDAQ:MMSI • US5898891040

68.88 USD
-0.83 (-1.19%)
Last: Mar 11, 2026, 11:17 AM

This MMSI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Taking everything into account, MMSI scores 6 out of 10 in our fundamental rating. MMSI was compared to 184 industry peers in the Health Care Equipment & Supplies industry. MMSI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. MMSI has a correct valuation and a medium growth rate. This makes MMSI very considerable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. MMSI Profitability Analysis

1.1 Basic Checks

  • In the past year MMSI was profitable.
  • MMSI had a positive operating cash flow in the past year.
  • MMSI had positive earnings in each of the past 5 years.
  • Each year in the past 5 years MMSI had a positive operating cash flow.
MMSI Yearly Net Income VS EBIT VS OCF VS FCFMMSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

1.2 Ratios

  • MMSI's Return On Assets of 4.78% is fine compared to the rest of the industry. MMSI outperforms 79.89% of its industry peers.
  • With a decent Return On Equity value of 8.11%, MMSI is doing good in the industry, outperforming 79.35% of the companies in the same industry.
  • MMSI's Return On Invested Capital of 6.07% is fine compared to the rest of the industry. MMSI outperforms 79.35% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MMSI is below the industry average of 9.15%.
  • The last Return On Invested Capital (6.07%) for MMSI is above the 3 year average (5.57%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.78%
ROE 8.11%
ROIC 6.07%
ROA(3y)4.61%
ROA(5y)4.25%
ROE(3y)8.23%
ROE(5y)7.17%
ROIC(3y)5.57%
ROIC(5y)5.14%
MMSI Yearly ROA, ROE, ROICMMSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4 6 8

1.3 Margins

  • MMSI's Profit Margin of 8.48% is amongst the best of the industry. MMSI outperforms 80.43% of its industry peers.
  • MMSI's Profit Margin has improved in the last couple of years.
  • MMSI has a Operating Margin of 12.60%. This is in the better half of the industry: MMSI outperforms 79.35% of its industry peers.
  • In the last couple of years the Operating Margin of MMSI has grown nicely.
  • With a Gross Margin value of 48.70%, MMSI perfoms like the industry average, outperforming 44.02% of the companies in the same industry.
  • MMSI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.6%
PM (TTM) 8.48%
GM 48.7%
OM growth 3Y17.72%
OM growth 5Y18.01%
PM growth 3Y9.41%
PM growth 5YN/A
GM growth 3Y2.59%
GM growth 5Y3.19%
MMSI Yearly Profit, Operating, Gross MarginsMMSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

7

2. MMSI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MMSI is destroying value.
  • MMSI has more shares outstanding than it did 1 year ago.
  • MMSI has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for MMSI has been reduced compared to a year ago.
MMSI Yearly Shares OutstandingMMSI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
MMSI Yearly Total Debt VS Total AssetsMMSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 3.84 indicates that MMSI is not in any danger for bankruptcy at the moment.
  • MMSI has a Altman-Z score of 3.84. This is in the better half of the industry: MMSI outperforms 74.46% of its industry peers.
  • MMSI has a debt to FCF ratio of 3.45. This is a good value and a sign of high solvency as MMSI would need 3.45 years to pay back of all of its debts.
  • MMSI has a better Debt to FCF ratio (3.45) than 81.52% of its industry peers.
  • MMSI has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
  • MMSI's Debt to Equity ratio of 0.46 is in line compared to the rest of the industry. MMSI outperforms 44.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.45
Altman-Z 3.84
ROIC/WACC0.65
WACC9.39%
MMSI Yearly LT Debt VS Equity VS FCFMMSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • MMSI has a Current Ratio of 4.34. This indicates that MMSI is financially healthy and has no problem in meeting its short term obligations.
  • MMSI has a Current ratio of 4.34. This is in the better half of the industry: MMSI outperforms 70.11% of its industry peers.
  • MMSI has a Quick Ratio of 2.95. This indicates that MMSI is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of MMSI (2.95) is better than 64.13% of its industry peers.
Industry RankSector Rank
Current Ratio 4.34
Quick Ratio 2.95
MMSI Yearly Current Assets VS Current LiabilitesMMSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

5

3. MMSI Growth Analysis

3.1 Past

  • MMSI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.06%, which is quite good.
  • Measured over the past years, MMSI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.34% on average per year.
  • Looking at the last year, MMSI shows a quite strong growth in Revenue. The Revenue has grown by 11.75% in the last year.
  • MMSI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.48% yearly.
EPS 1Y (TTM)10.06%
EPS 3Y12.5%
EPS 5Y18.34%
EPS Q2Q%11.83%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y9.61%
Revenue growth 5Y9.48%
Sales Q2Q%10.92%

3.2 Future

  • MMSI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.85% yearly.
  • The Revenue is expected to grow by 6.40% on average over the next years.
EPS Next Y8.19%
EPS Next 2Y8.2%
EPS Next 3Y7.37%
EPS Next 5Y6.85%
Revenue Next Year6.94%
Revenue Next 2Y6.32%
Revenue Next 3Y5.95%
Revenue Next 5Y6.4%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MMSI Yearly Revenue VS EstimatesMMSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
MMSI Yearly EPS VS EstimatesMMSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

6

4. MMSI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.98, which indicates a rather expensive current valuation of MMSI.
  • Based on the Price/Earnings ratio, MMSI is valued a bit cheaper than the industry average as 79.89% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.25. MMSI is valued slightly cheaper when compared to this.
  • MMSI is valuated correctly with a Price/Forward Earnings ratio of 16.62.
  • Based on the Price/Forward Earnings ratio, MMSI is valued cheaply inside the industry as 83.15% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of MMSI to the average of the S&P500 Index (24.39), we can say MMSI is valued slightly cheaper.
Industry RankSector Rank
PE 17.98
Fwd PE 16.62
MMSI Price Earnings VS Forward Price EarningsMMSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MMSI is valued cheaper than 81.52% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MMSI indicates a rather cheap valuation: MMSI is cheaper than 90.76% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.26
EV/EBITDA 14.1
MMSI Per share dataMMSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • MMSI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.2
PEG (5Y)0.98
EPS Next 2Y8.2%
EPS Next 3Y7.37%

0

5. MMSI Dividend Analysis

5.1 Amount

  • MMSI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MMSI Fundamentals: All Metrics, Ratios and Statistics

MERIT MEDICAL SYSTEMS INC

NASDAQ:MMSI (3/11/2026, 11:17:04 AM)

68.88

-0.83 (-1.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-24
Earnings (Next)04-22
Inst Owners106.93%
Inst Owner Change-34.95%
Ins Owners0.41%
Ins Owner Change9.14%
Market Cap4.09B
Revenue(TTM)1.52B
Net Income(TTM)128.49M
Analysts84.44
Price Target106.08 (54.01%)
Short Float %6.5%
Short Ratio5.38
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.64%
Min EPS beat(2)6.87%
Max EPS beat(2)8.41%
EPS beat(4)4
Avg EPS beat(4)11.07%
Min EPS beat(4)6.87%
Max EPS beat(4)16.43%
EPS beat(8)8
Avg EPS beat(8)8.59%
EPS beat(12)12
Avg EPS beat(12)8.9%
EPS beat(16)16
Avg EPS beat(16)11.03%
Revenue beat(2)1
Avg Revenue beat(2)0.16%
Min Revenue beat(2)-0.94%
Max Revenue beat(2)1.27%
Revenue beat(4)2
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-1.19%
Max Revenue beat(4)1.27%
Revenue beat(8)3
Avg Revenue beat(8)-0.27%
Revenue beat(12)6
Avg Revenue beat(12)0.27%
Revenue beat(16)9
Avg Revenue beat(16)0.68%
PT rev (1m)-0.35%
PT rev (3m)0.97%
EPS NQ rev (1m)-6.3%
EPS NQ rev (3m)-6.3%
EPS NY rev (1m)0.4%
EPS NY rev (3m)1.26%
Revenue NQ rev (1m)-0.53%
Revenue NQ rev (3m)-0.39%
Revenue NY rev (1m)0.73%
Revenue NY rev (3m)0.73%
Valuation
Industry RankSector Rank
PE 17.98
Fwd PE 16.62
P/S 2.7
P/FCF 19.26
P/OCF 13.77
P/B 2.58
P/tB 7.58
EV/EBITDA 14.1
EPS(TTM)3.83
EY5.56%
EPS(NY)4.14
Fwd EY6.02%
FCF(TTM)3.58
FCFY5.19%
OCF(TTM)5
OCFY7.26%
SpS25.51
BVpS26.66
TBVpS9.08
PEG (NY)2.2
PEG (5Y)0.98
Graham Number47.93
Profitability
Industry RankSector Rank
ROA 4.78%
ROE 8.11%
ROCE 7.81%
ROIC 6.07%
ROICexc 7.42%
ROICexgc 15.54%
OM 12.6%
PM (TTM) 8.48%
GM 48.7%
FCFM 14.02%
ROA(3y)4.61%
ROA(5y)4.25%
ROE(3y)8.23%
ROE(5y)7.17%
ROIC(3y)5.57%
ROIC(5y)5.14%
ROICexc(3y)7.03%
ROICexc(5y)6.1%
ROICexgc(3y)14.25%
ROICexgc(5y)12.17%
ROCE(3y)7.17%
ROCE(5y)6.61%
ROICexgc growth 3Y19%
ROICexgc growth 5Y21.1%
ROICexc growth 3Y14.16%
ROICexc growth 5Y20.69%
OM growth 3Y17.72%
OM growth 5Y18.01%
PM growth 3Y9.41%
PM growth 5YN/A
GM growth 3Y2.59%
GM growth 5Y3.19%
F-Score7
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.45
Debt/EBITDA 2.34
Cap/Depr 68.88%
Cap/Sales 5.6%
Interest Coverage 9.1
Cash Conversion 94.65%
Profit Quality 165.41%
Current Ratio 4.34
Quick Ratio 2.95
Altman-Z 3.84
F-Score7
WACC9.39%
ROIC/WACC0.65
Cap/Depr(3y)48.9%
Cap/Depr(5y)47.67%
Cap/Sales(3y)3.77%
Cap/Sales(5y)3.62%
Profit Quality(3y)144.04%
Profit Quality(5y)153.03%
High Growth Momentum
Growth
EPS 1Y (TTM)10.06%
EPS 3Y12.5%
EPS 5Y18.34%
EPS Q2Q%11.83%
EPS Next Y8.19%
EPS Next 2Y8.2%
EPS Next 3Y7.37%
EPS Next 5Y6.85%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y9.61%
Revenue growth 5Y9.48%
Sales Q2Q%10.92%
Revenue Next Year6.94%
Revenue Next 2Y6.32%
Revenue Next 3Y5.95%
Revenue Next 5Y6.4%
EBIT growth 1Y16.34%
EBIT growth 3Y29.03%
EBIT growth 5Y29.19%
EBIT Next Year32.4%
EBIT Next 3Y16.34%
EBIT Next 5Y13.39%
FCF growth 1Y16.29%
FCF growth 3Y45.29%
FCF growth 5Y12.87%
OCF growth 1Y34.68%
OCF growth 3Y37.54%
OCF growth 5Y12.46%

MERIT MEDICAL SYSTEMS INC / MMSI FAQ

Can you provide the ChartMill fundamental rating for MERIT MEDICAL SYSTEMS INC?

ChartMill assigns a fundamental rating of 6 / 10 to MMSI.


What is the valuation status for MMSI stock?

ChartMill assigns a valuation rating of 6 / 10 to MERIT MEDICAL SYSTEMS INC (MMSI). This can be considered as Fairly Valued.


How profitable is MERIT MEDICAL SYSTEMS INC (MMSI) stock?

MERIT MEDICAL SYSTEMS INC (MMSI) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for MMSI stock?

The Price/Earnings (PE) ratio for MERIT MEDICAL SYSTEMS INC (MMSI) is 17.98 and the Price/Book (PB) ratio is 2.58.


What is the financial health of MERIT MEDICAL SYSTEMS INC (MMSI) stock?

The financial health rating of MERIT MEDICAL SYSTEMS INC (MMSI) is 7 / 10.